Sex differences in immune responses that underlie COVID-19 disease outcomes

Abstract

CLIA-certified laboratories were enrolled through the IMPACT biorepository study 15. In the IMPACT study, biospecimens including blood, nasopharyngeal swabs, saliva, urine and stool samples were collected at study enrolment (baseline denotes the first time point) and longitudinally on average every 3 to 7 days (serial time points). The detailed demographics and clinical characteristics of these 98 participants are shown in Extended Data Table 1. Plasma and peripheral blood mononuclear cells (PBMCs) were isolated from whole blood, and plasma was used for titre measurements of SARS-CoV-2 spike S1 protein-specific IgG and IgM antibodies (anti-S1-IgG and-IgM) and cytokine or chemokine measurements. Freshly isolated PBMCs were stained and analysed by flow cytometry 15. We obtained longitudinal serial time-point samples from a subset of these 98 study participants (n = 48; information in Extended Data Table 1). To compare the immune phenotypes between sexes, two sets of data analyses were performed in parallel-baseline and longitudinal, as described below. As a control group, healthcare workers (HCWs) from Yale-New Haven Hospital were enrolled who were uninfected with COVID-19. Demographics and background information for the HCW group and the demographics of HCWs for cytokine assays and flow cytometry assays for the primary analyses are in Extended Data Table 1. Demographic data, time-point information of the samples defined by the days from the symptom onset (DFSO) in each patient, treatment information, and raw data used to generate figures and tables is in Supplementary Table 1. Baseline analysis The baseline analysis was performed on samples from the first time point of patients who met the following criteria: not in intensive care unit (ICU), had not received tocilizumab, and had not received high doses of corticosteroids (prednisone equivalent of more than 40 mg) before the first sample collection date. This patient group, cohort A, consisted of 39 patients (17 male and 22 female) (Extended Data Tables 1, 2). Intersex and transgender individuals were not represented in this study. Figures 1-4 represent analyses of baseline raw values obtained from patients in cohort A. In cohort A patients, male and female patients were matched in terms of age, body mass index (BMI), and DFSO at the first time point sample collection (Extended Data Fig. 1a). However, there were significant differences in age and BMI between HCW controls and patients (patients had higher age and BMI values) (Extended Data Table 1), and therefore an age-and BMI-adjusted difference-indifferences analysis was also performed in parallel (Extended Data Table 3). Longitudinal analysis As parallel secondary analyses, we performed longitudinal analysis on a total patient cohort (cohort B) to evaluate the difference in immune response over the course of the disease between male and female patients. Cohort B included all patient samples from cohort A (including several time-point samples from the cohort A patients) as well as an additional 59 patients who d...

Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19

“…Translational studies in adult COVID-19 identified T cell lymphopenia in particular, with a preferential decrease in CD8 T cells compared to CD4 T cells [21][22][23] . In those lymphocytes remaining, marked activation of CD4 and CD8 T cells was observed, and T cell activation correlated positively with severity of illness 22,[24][25][26][27][28] . However, even among the sickest adults, the degree of immune activation varies 22,24,25,29 .…”

Why Individuals Respond To COVID-19 Differently: A Battle of Sexes?

“…Another factor to consider is whether the sex of the patient affects the level of inflammatory mediators such as cytokines in the body. Although a study illustrates there is a similar level of IL-8 and IL-18 between males and females who have severe SARS-CoV-2 infections, this is not concordant with other findings in the study (30). For example, the concentration of IFNA2 is higher in females, however levels of CCL5 are more elevated in males during the pathogenesis of the disease (30).…”

T cell anergy in COVID-19 reflects virus persistence and poor outcomes

“…Gender speci c analysis showed that the T cell-induced upregulation of CD123 on monocytes was signi cantly higher in healthy males and non-ventilated male patients than in the same groups of females. As IL-3 contributes to activation of monocytes 33 , the stronger T cell -monocyte link in males may explain the recently described higher plasma levels of IL-8 and IL-18 in male COVID-19 patients 34 .…”